Concepedia

Publication | Open Access

Preclinical safety and activity of recombinant VSV‐IFN‐β in an immunocompetent model of squamous cell carcinoma of the head and neck

23

Citations

27

References

2013

Year

Abstract

The above data confirm safety and feasibility of VSV-IFN-β administration in immunocompetent animals and support its clinical evaluation in advanced human head and neck cancer.

References

YearCitations

Page 1